Market research
009290.KO Kwang Dong Pharmaceutical Co., Ltd
KO KRW Consumer Defensive
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 323B
- P/E ratio
- 15.1
- Analyst target
- 12000
- Dividend yield
- 1.5%
- Beta
- 0.35
Profile
Instrument facts
- Exchange
- KO
- Currency
- KRW
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- KR7009290008
- Market cap
- 323B
- P/E ratio
- 15.1
- Analyst target
- 12000
- Dividend yield
- 1.5%
- Beta
- 0.35
About
About Kwang Dong Pharmaceutical Co., Ltd
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vitamin, mineral or vital energy substance and quasi drugs. In addition, it provides blackberry, ginger lonicerae flos, vita gold, and red ginseng gold drinks, as well as offers water, mixed drinks, tea drinks, and other drinks; and traditional health foods. The company offers its products through operation of TV, radio, and print advertising. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.
Research context
Kwang Dong Pharmaceutical Co., Ltd appears in PyInvesting’s Korea Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- KRW
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 009290.KO discussion.
5 years, 6 months ago
Kwang Dong Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 4.5% below its 200 day moving average.
From a valuation standpoint, the stock is 96.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
Kwang Dong Pharmaceutical Co., Ltd's total revenue sank by 4.0% to $305B since the same quarter in the previous year.
Its net income has dropped by 375.9% to $-7B since the same quarter in the previous year.
Finally, its free cash flow fell by 49.7% to $9B since the same quarter in the previous year.
Based on the above factors, Kwang Dong Pharmaceutical Co., Ltd gets an overall score of 1/5.